ADRENOCORTICAL CARCINOMA
Clinical trials for ADRENOCORTICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADRENOCORTICAL CARCINOMA trials appear
Sign up with your email to follow new studies for ADRENOCORTICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive bullet targets advanced cancers in early trial
Disease control TerminatedThis early-stage study tested a new radioactive drug designed to target and destroy advanced solid tumors. It involved 78 patients with various cancers who had run out of standard treatment options. The main goals were to check the treatment's safety, find the right dose, and see…
Matched conditions: ADRENOCORTICAL CARCINOMA
Phase: PHASE1 • Sponsor: Fusion Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Experimental vaccine fights rare adrenal cancers
Disease control TerminatedThis study tested a new cancer vaccine called EO2401 combined with an immunotherapy drug for people with advanced adrenal cancers that had spread. The goal was to see if this combination was safe and could help control these rare, aggressive tumors. The trial enrolled 70 adults w…
Matched conditions: ADRENOCORTICAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Enterome • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC